The civic record
Read. Follow. Verify.Senate Hearing on Preventing Falls Among Seniors
Record date · January 1, 2022
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
This Senate Special Committee on Aging hearing examined the causes of falls among older Americans and discussed potential solutions to reduce injuries. The committee reviewed a bipartisan report highlighting the $50 billion annual cost of fall-related injuries and the impact of medication interactions and osteoporosis on senior safety.
The committee is evaluating legislative and policy changes to Medicare reimbursement for and FDA drug trial requirements, which directly affect the healthcare costs and medical screening access for millions of seniors.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Medicare beneficiaries
Seniors covered by Medicare are affected by changes in reimbursement rates for bone density testing and potential updates to medication reconciliation during wellness visits.
Healthcare providers
Clinicians and service providers are involved in implementing fall prevention strategies and managing medication reviews for older patients.
Pharmaceutical companies
Companies may be required to ensure older adults are adequately represented in clinical trials per the FDA funding bill directives.
Key Facts
- Fall-related injuries cost the U.S. approximately $50 billion annually, with costs expected to reach $100 billion by 2030.
- Medicare and Medicaid cover 75% of all fall-related injury costs.
- Medicare reimbursement rates for bone density testing have been reduced by 70% since 2006.
- The reduction in bone density testing reimbursement is linked to 2.3 million fewer women being tested and an estimated 40,000 additional hip fractures annually.
Show all 8 facts
- 90% of older Americans take at least one prescription medication, and 36% take five or more, increasing fall risks due to drug interactions.
- The Fiscal Year 2020 FDA funding bill directs the agency to assess drug interaction impacts and ensure older adults are represented in clinical trials.
- Falls are the leading cause of fatal and non-fatal injuries for older Americans.
- The committee received input from nearly 200 organizations regarding fall prevention strategies.
Frequently Asked Questions
Why are falls considered a major public health issue for seniors?
What is the connection between bone density testing and hip fractures?
How do medications contribute to the risk of falling?
What else do you want to know?
News Coverage
Bias ratings based on AllSides / Media Bias/Fact Check
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Focus on Clinical Trial Representation
The committee is pushing for a policy shift requiring the FDA to ensure older adults are better represented in clinical trials to mitigate medication-related fall risks.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz25Current news / social attention level
Publisher tools